FilingIndex
10-KThe Record

Acrivon Therapeutics, Inc. files 10-K

Filed Mar 19, 2026 · 3mo ago · Accession 0001193125-26-115123

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
ACRV
CIK
1781174
Form type
10-K
Filing date
Mar 19, 2026
Report date
Dec 31, 2025
Document
acrv-20251231.htm
Size
11.8 MB